Key result
Resection of retroperitoneal sarcoma has seen decreased morbidity over time, with acceptable long-term functional outcomes, though intraoperative and brachytherapy techniques increase toxicities.
Why the study?
What are the morbidity, complication rates, and functional outcomes associated with retroperitoneal sarcoma resection?
What are the morbidity, complication rates, and functional outcomes associated with retroperitoneal sarcoma resection?
While retroperitoneal sarcoma resection carries morbidity risks, particularly in the elderly and with certain radiotherapy techniques, long-term functional and quality of life outcomes remain acceptable.
Supports resection of retroperitoneal sarcoma given improving morbidity; leaves open optimization of radiotherapy techniques to minimize toxicities.
Resection of retroperitoneal sarcoma (RPS) typically involves multivisceral resection. The morbidity of RPS resection has decreased over time despite widespread adoption of radical resection. Certain patterns of resection are associated with higher complication rates and elderly patients are at increased risk of morbidity. Administration of preoperative radiotherapy does not increase morbidity, but intraoperative and brachytherapy techniques are associated with heightened toxicities. Long-term functional outcomes and quality of life scores after RPS resection are acceptable.
No takes yet. Share an insight, caveat, or question.
MacNeill et al. (2018) conducted a review in Retroperitoneal sarcoma (RPS). Resection of retroperitoneal sarcoma was evaluated on Surgical morbidity. Resection of retroperitoneal sarcoma has seen decreased morbidity over time, with acceptable long-term functional outcomes, though intraoperative and brachytherapy techniques increase toxicities.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: